Influence of common genetic variation on lung cancer risk: Meta-analysis of 14 900 cases and 29 485 controls

Human Molecular Genetics

Volumn 21, Issue 22, 2012, Pages 4980-4995

  Timofeeva, Maria N ^a   Hung, Rayjean J ^b   Rafnar, Thorunn ^c   Christiani, David C ^d   Field, John K ^e   Bickeböller, Heike ^f   Risch, Angela ^g,am   Mckay, James D ^a   Wang, Yufei ^h   Dai, Juncheng ⁱ   Gaborieau, Valerie ^a   Mclaughlin, John ^b   Brenner, Darren ^b   Narod, Steven A ^j   Caporaso, Neil E ^k   Albanes, Demetrius ^k   Thun, Michael ^l   Eisen, Timothy ^m   Wichmann, H Erich ^n,o   Rosenberger, Albert ^f   Han, Younghun ^p   Chen, Wei ^p   Zhu, Dakai ^p   Spitz, Margaret ^q   Wu, Xifeng ^p   Pande, Mala ^p   Zhao, Yang ^d   Zaridze, David ^r   Szeszenia dabrowska, Neonilia ^s   Lissowska, Jolanta ^t   Rudnai, Peter ^u   Fabianova, Eleonora ^v   Mates, Dana ^w   Bencko, Vladimir ^x   Foretova, Lenka ^y   Janout, Vladimir ^z   Krokan, Hans E ^aa   Gabrielsen, Maiken Elvestad ^aa   Skorpen, Frank ^ab   Vatten, Lars ^aa   NjØlstad, Inger ^ac   Chen, Chu ^ad   Goodman, Gary ^ad   Lathrop, Mark ^ae   Benhamou, Simone ^af   Vooder, TÕnu ^ag   Välk, Kristjan ^ah   Nelis, Mari ^ai,aj   Metspalu, Andres ^ai   Raji, Olaide ^e   Chen, Ying ^e   Gosney, John ^e   Liloglou, Triantafillos ^e   Muley, Thomas ^ak,am   Dienemann, Hendrik ^al,am   Thorleifsson, Gudmar ^c   Shen, Hongbing ⁱ   Stefansson, Kari ^c   Brennan, Paul ^a   Amos, Christopher I ^p,an   Houlston, Richard ^h   Landi, Maria Teresa ^k   more..

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b MOUNT SINAI HOSPITAL   (Canada)

^c DECODE GENETICS   (Iceland)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e UNIVERSITY OF LIVERPOOL   (United Kingdom)

^f UNIVERSITY OF GÖTTINGEN   (Germany)

^g GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^h INSTITUTE OF CANCER RESEARCH   (United Kingdom)

ⁱ NANJING MEDICAL UNIVERSITY   (China)

^j WOMEN S COLLEGE HOSPITAL   (Canada)

^k NATIONAL CANCER INSTITUTE   (United States)

^l AMERICAN CANCER SOCIETY   (United States)

^m CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

ⁿ INSTITUTE OF EPIDEMIOLOGY   (Germany)

^o UNIVERSITY OF MUNICH   (Germany)

^p UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^q BAYLOR COLLEGE OF MEDICINE   (United States)

^r N N BLOKHIN RUSSIAN CANCER RESEARCH CENTER   (Russian Federation)

^s NOFER INSTITUTE OF OCCUPATIONAL MEDICINE   (Poland)

^t INSTITUTE OF ONCOLOGY   (Poland)

^u NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH   (Hungary)

^v Regional Authority of Public Health   (Slovakia)

^w NATIONAL INSTITUTE OF PUBLIC HEALTH   (Romania)

^x CHARLES UNIVERSITY   (Czech Republic)

^y MASARYK MEMORIAL CANCER INSTITUTE   (Czech Republic)

^z PALACKÝ UNIVERSITY   (Czech Republic)

^aa NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^ab NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^ac UNIVERSITY OF TROMSØ   (Norway)

^ad Fred Hutchinson Cancer Research Center   (United States)

^ae FONDATION JEAN DAUSSET CEPH   (France)

^af INSERM   (France)

^ag UNIVERSITY OF TARTU   (Estonia)

^ah Competence Centre on Reproductive Medicine and Biology ^*  (Estonia)

^ai UNIVERSITY OF TARTU   (Estonia)

^aj UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^ak Translational Research Unit   (Germany)

^al UNIVERSITY OF HEIDELBERG   (Germany)

^am Member of the German Center for Lung Research   (Germany)

^an DARTMOUTH MEDICAL SCHOOL   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; CYCLIN DEPENDENT KINASE INHIBITOR 2B;

ARTICLE; CANCER RISK; CHINESE; CHROMOSOME 12P; CHROMOSOME 15Q; CHROMOSOME 5P; CHROMOSOME 6P; CHROMOSOME 9P; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HISTOPATHOLOGY; HUMAN; LUNG CANCER; LUNG SQUAMOUS CELL CARCINOMA; META ANALYSIS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC VARIATION; GENOME-WIDE ASSOCIATION STUDY; HUMANS; LUNG NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK;

EID: 84868156549     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/dds334     Document Type: Article

References (92)

1. Parkin, D.M., Bray, F., Ferlay, J. and Pisani, P. (2005) Global cancer statistics, 2002. CA Cancer J. Clin., 55, 74-108.
2. Gazdar, A., Franklin, W.A., Brambilla, E., Hainaut, P., Yokota, J. and Harris, C.C. (2004) In Travis, W.D., Brambilla, E., Muller-Hermelink, H.K. and Harris, C.C. (eds), World Health Organization Classification of Tumors. Pathology and Genetics of Tumors of the Lung, Pleura and Heart. IARCPress, Lyon, pp. 21-23.
3. Brennan, P., Hainaut, P. and Boffetta, P. (2011) Genetics of lung-cancer susceptibility. Lancet Oncol., 12, 399-408.
4. Hung, R.J., McKay, J.D., Gaborieau, V., Boffetta, P., Hashibe, M., Zaridze, D., Mukeria, A., Szeszenia-Dabrowska, N., Lissowska, J., Rudnai, P. et al. (2008) A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature, 452, 633-637.
5. Amos, C.I., Wu, X., Broderick, P., Gorlov, I.P., Gu, J., Eisen, T., Dong, Q., Zhang, Q., Gu, X., Vijayakrishnan, J. et al. (2008) Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1. Nat. Genet., 40, 616-622.
6. McKay, J.D., Hung, R.J., Gaborieau, V., Boffetta, P., Chabrier, A., Byrnes, G., Zaridze, D., Mukeria, A., Szeszenia-Dabrowska, N., Lissowska, J. et al. (2008) Lung cancer susceptibility locus at 5p15.33. Nat. Genet., 40, 1404-1406.
7. Wang, Y., Broderick, P., Webb, E., Wu, X., Vijayakrishnan, J., Matakidou, A., Qureshi, M., Dong, Q., Gu, X., Chen, W.V. et al. (2008) Common 5p15.33 and 6p21.33 variants influence lung cancer risk. Nat. Genet., 40, 1407-1409.
8. Broderick, P., Wang, Y., Vijayakrishnan, J., Matakidou, A., Spitz, M.R., Eisen, T., Amos, C.I. and Houlston, R.S. (2009) Deciphering the impact of common genetic variation on lung cancer risk: a genome-wide association study. Cancer Res., 69, 6633-6641.
9. Thorgeirsson, T.E., Geller, F., Sulem, P., Rafnar, T., Wiste, A., Magnusson, K.P., Manolescu, A., Thorleifsson, G., Stefansson, H., Ingason, A. et al. (2008) A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature, 452, 638-642.
10. Brennan, P., McKay, J., Moore, L., Zaridze, D., Mukeria, A., Szeszenia-Dabrowska, N., Lissowska, J., Rudnai, P., Fabianova, E., Mates, D. et al. (2007) Uncommon CHEK2 mis-sense variant and reduced risk of tobacco-related cancers: case control study. Hum. Mol. Genet., 16, 1794-1801.
11. Cybulski, C., Masojc, B., Oszutowska, D., Jaworowska, E., Grodzki, T., Waloszczyk, P., Serwatowski, P., Pankowski, J., Huzarski, T., Byrski, T. et al. (2008) Constitutional CHEK2 mutations are associated with a decreased risk of lung and laryngeal cancers. Carcinogenesis, 29, 762-765.
12. Rudd, M.F., Webb, E.L., Matakidou, A., Sellick, G.S., Williams, R.D., Bridle, H., Eisen, T. and Houlston, R.S. (2006) Variants in the GH-IGF axis confer susceptibility to lung cancer. Genome Res., 16, 693-701.
13. Rafnar, T., Sulem, P., Besenbacher, S., Gudbjartsson, D.F., Zanon, C., Gudmundsson, J., Stacey, S.N., Kostic, J.P., Thorgeirsson, T.E., Thorleifsson, G. et al. (2011) Genome-wide significant association between a sequence variant at 15q15.2 and lung cancer risk. Cancer Res., 71, 1356-1361.
14. Truong, T., Sauter, W., McKay, J.D., Hosgood, H.D. III, Gallagher, C., Amos, C.I., Spitz, M., Muscat, J., Lazarus, P., Illig, T. et al. (2010) International Lung Cancer Consortium: coordinated association study of 10 potential lung cancer susceptibility variants. Carcinogenesis, 31, 625-633.
15. Hu, Z., Wu, C., Shi, Y., Guo, H., Zhao, X., Yin, Z., Yang, L., Dai, J., Hu, L., Tan, W. et al. (2011) A genome-wide association study identifies two new lung cancer susceptibility loci at 13q12.12 and 22q12.2 in Han Chinese. Nat. Genet., 43, 792-796.
16. Miki, D., Kubo, M., Takahashi, A., Yoon, K.A., Kim, J., Lee, G.K., Zo, J.I., Lee, J.S., Hosono, N., Morizono, T. et al. (2010) Variation in TP63 is associated with lung adenocarcinoma susceptibility in Japanese and Korean populations. Nat. Genet., 42, 893-896.
17. Truong, T., Hung, R.J., Amos, C.I., Wu, X., Bickeboller, H., Rosenberger, A., Sauter, W., Illig, T., Wichmann, H.E., Risch, A. et al. (2010) Replication of lung cancer susceptibility loci at chromosomes 15q25, 5p15, and 6p21: a pooled analysis from the International Lung Cancer Consortium. J. Natl. Cancer Inst., 102, 959-971.
18. Landi, M.T., Chatterjee, N., Yu, K., Goldin, L.R., Goldstein, A.M., Rotunno, M., Mirabello, L., Jacobs, K., Wheeler, W., Yeager, M. et al. (2009) A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma. Am. J. Hum. Genet., 85, 679-691.
19. Shi, J., Chatterjee, N., Rotunno, M., Wang, Y., Pesatori, A.C., Consonni, D., Li, P., Wheeler, W., Broderick, P., Henrion, M. et al. (2012) Inherited variation at chromosome 12p13.33 including RAD52 influences squamous cell lung carcinoma risk. Cancer Disc., 2, 131-139.
20. Yang, J., Weedon, M.N., Purcell, S., Lettre, G., Estrada, K., Willer, C.J., Smith, A.V., Ingelsson, E., O'Connell, J.R., Mangino, M. et al. (2011) Genomic inflation factors under polygenic inheritance. Eur. J. Hum. Genet., 19, 807-812.
21. Freedman, M.L., Reich, D., Penney, K.L., McDonald, G.J., Mignault, A.A., Patterson, N., Gabriel, S.B., Topol, E.J., Smoller, J.W., Pato, C.N. et al. (2004) Assessing the impact of population stratification on genetic association studies. Nat. Genet., 36, 388-393.
22. Hawryluk-Gara, L.A., Platani, M., Santarella, R., Wozniak, R.W. and Mattaj, I.W. (2008) Nup53 is required for nuclear envelope and nuclear pore complex assembly. Mol. Biol. Cell, 19, 1753-1762.
23. Kiyohara, C., Horiuchi, T., Miyake, Y., Takayama, K. and Nakanishi, Y. (2010) Cigarette smoking, TP53 Arg72Pro, TP53BP1 Asp353Glu and the risk of lung cancer in a Japanese population. Oncol. Rep., 23, 1361-1368.
24. Yoon, K.A., Park, J.H., Han, J., Park, S., Lee, G.K., Han, J.Y., Zo, J.I., Kim, J., Lee, J.E., Takahashi, A. et al. (2010) A genome-wide association study reveals susceptibility variants for non-small cell lung cancer in the Korean population. Hum. Mol. Genet., 19, 4948-4954.
25. Etzel, C.J., Lu, M., Merriman, K., Liu, M., Vaporciyan, A. and Spitz, M.R. (2006) An epidemiologic study of early onset lung cancer. Lung Cancer, 52, 129-134.
26. la Cruz, C.S., Tanoue, L.T. and Matthay, R.A. (2011) Lung cancer: epidemiology, etiology, and prevention. Clin. Chest Med., 32, 605-644.
27. Subramanian, J., Morgensztern, D., Goodgame, B., Baggstrom, M.Q., Gao, F., Piccirillo, J. and Govindan, R. (2010) Distinctive characteristics of non-small cell lung cancer (NSCLC) in the young: a surveillance, epidemiology, and end results (SEER) analysis. J. Thorac. Oncol., 5, 23-28.
28. Strazisar, M., Mlakar, V. and Glavac, D. (2009) The expression of COX-2, hTERT, MDM2, LATS2 and S100A2 in different types of non-small cell lung cancer (NSCLC). Cell. Mol. Biol. Lett., 14, 442-456.
29. Xie, M., Chen, Q., He, S., Li, B. and Hu, C. (2011) Silencing of the human TERT gene by RNAi inhibits A549 lung adenocarcinoma cell growth in vitro and in vivo. Oncol. Rep., 26, 1019-1027.
30. Zienolddiny, S., Skaug, V., Landvik, N.E., Ryberg, D., Phillips, D.H., Houlston, R. and Haugen, A. (2009) The TERT-CLPTM1L lung cancer susceptibility variant associates with higher DNA adduct formation in the lung. Carcinogenesis, 30, 1368-1371.
31. Jaworowska, E., Trubicka, J., Lener, M.R., Masojc, B., Zlowocka-Perlowska, E., McKay, J.D., Renard, H., Oszutowska, D., Wokolorczyk, D., Lubinski, J. et al. (2011) Smoking related cancers and loci at chromosomes 15q25, 5p15, 6p22.1 and 6p21.33 in the Polish population. PLoS One, 6, e25057.
32. Takayama, S. and Reed, J.C. (2001) Molecular chaperone targeting and regulation by BAG family proteins. Nat. Cell Biol., 3, E237-E241.
33. Desmots, F., Russell, H.R., Lee, Y., Boyd, K. and McKinnon, P.J. (2005) The reaper-binding protein scythe modulates apoptosis and proliferation during mammalian development. Mol. Cell Biol., 25, 10329-10337.
34. Sasaki, T., Gan, E.C., Wakeham, A., Kornbluth, S., Mak, T.W. and Okada, H. (2007) HLA-B-associated transcript 3 (Bat3)/Scythe is essential for p300-mediated acetylation of p53. Genes Dev., 21, 848-861.
35. Parkinson, H., Sarkans, U., Kolesnikov, N., Abeygunawardena, N., Burdett, T., Dylag, M., Emam, I., Farne, A., Hastings, E., Holloway, E. et al. (2011) ArrayExpress update-an archive of microarray and high-throughput sequencing-based functional genomics experiments. Nucleic Acids Res., 39, D1002-D1004.
36. Thierry-Mieg, D. and Thierry-Mieg, J. (2006) AceView: a comprehensive cDNA-supported gene and transcripts annotation. Genome Biol., 7(Suppl. 1), S12-S14.
37. Gil, J. and Peters, G. (2006) Regulation of the INK4b-ARF-INK4a tumour suppressor locus: all for one or one for all. Nat. Rev. Mol. Cell Biol., 7, 667-677.
38. Hussussian, C.J., Struewing, J.P., Goldstein, A.M., Higgins, P.A., Ally, D.S., Sheahan, M.D., Clark, W.H. Jr, Tucker, M.A. and Dracopoli, N.C. (1994) Germline p16 mutations in familial melanoma. Nat. Genet., 8, 15-21.
39. Hamada, K., Kohno, T., Kawanishi, M., Ohwada, S. and Yokota, J. (1998) Association of CDKN2A(p16)/CDKN2B(p15) alterations and homozygous chromosome arm 9p deletions in human lung carcinoma. Genes Chromosomes. Cancer, 22, 232-240.
40. Washimi, O., Nagatake, M., Osada, H., Ueda, R., Koshikawa, T., Seki, T., Takahashi, T. and Takahashi, T. (1995) In vivo occurrence of p16 (MTS1) and p15 (MTS2) alterations preferentially in non-small cell lung cancers. Cancer Res., 55, 514-517.
41. Xiao, S., Li, D., Corson, J.M., Vijg, J. and Fletcher, J.A. (1995) Codeletion of p15 and p16 genes in primary non-small cell lung carcinoma. Cancer Res., 55, 2968-2971.
42. Hawes, S.E., Stern, J.E., Feng, Q., Wiens, L.W., Rasey, J.S., Lu, H., Kiviat, N.B. and Vesselle, H. (2010) DNA hypermethylation of tumors from non-small cell lung cancer (NSCLC) patients is associated with gender and histologic type. Lung Cancer, 69, 172-179.
43. Pasmant, E., Sabbagh, A., Vidaud, M. and Bieche, I. (2011) ANRIL, a long, noncoding RNA, is an unexpected major hotspot in GWAS. FASEB J., 25, 444-448.
44. Burdon, K.P., Macgregor, S., Hewitt, A.W., Sharma, S., Chidlow, G., Mills, R.A., Danoy, P., Casson, R., Viswanathan, A.C., Liu, J.Z. et al. (2011) Genome-wide association study identifies susceptibility loci for open angle glaucoma at TMCO1 and CDKN2B-AS1. Nat. Genet., 43, 574-578.
45. Wrensch, M., Jenkins, R.B., Chang, J.S., Yeh, R.F., Xiao, Y., Decker, P.A., Ballman, K.V., Berger, M., Buckner, J.C., Chang, S. et al. (2009) Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility. Nat. Genet., 41, 905-908.
46. Shete, S., Hosking, F.J., Robertson, L.B., Dobbins, S.E., Sanson, M., Malmer, B., Simon, M., Marie, Y., Boisselier, B., Delattre, J.Y. et al. (2009) Genome-wide association study identifies five susceptibility loci for glioma. Nat. Genet., 41, 899-904.
47. Takeuchi, F., Serizawa, M., Yamamoto, K., Fujisawa, T., Nakashima, E., Ohnaka, K., Ikegami, H., Sugiyama, T., Katsuya, T., Miyagishi, M. et al. (2009) Confirmation of multiple risk Loci and genetic impacts by a genome-wide association study of type 2 diabetes in the Japanese population. Diabetes, 58, 1690-1699.
48. Voight, B.F., Scott, L.J., Steinthorsdottir, V., Morris, A.P., Dina, C., Welch, R.P., Zeggini, E., Huth, C., Aulchenko, Y.S., Thorleifsson, G. et al. (2010) Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat. Genet., 42, 579-589.
49. Parra, E.J., Below, J.E., Krithika, S., Valladares, A., Barta, J.L., Cox, N.J., Hanis, C.L., Wacher, N., Garcia-Mena, J., Hu, P. et al. (2011) Genome-wide association study of type 2 diabetes in a sample from Mexico City and a meta-analysis of a Mexican-American sample from Starr County, Texas. Diabetologia, 54, 2038-2046.
50. Uno, S., Zembutsu, H., Hirasawa, A., Takahashi, A., Kubo, M., Akahane, T., Aoki, D., Kamatani, N., Hirata, K. and Nakamura, Y. (2010) A genome-wide association study identifies genetic variants in the CDKN2BAS locus associated with endometriosis in Japanese. Nat. Genet., 42, 707-710.
51. Takeuchi, F., Yokota, M., Yamamoto, K., Nakashima, E., Katsuya, T., Asano, H., Isono, M., Nabika, T., Sugiyama, T., Fujioka, A. et al. (2012) Genome-wide association study of coronary artery disease in the Japanese. Eur. J. Hum. Genet., 20, 333-340.
52. Schunkert, H., Konig, I.R., Kathiresan, S., Reilly, M.P., Assimes, T.L., Holm, H., Preuss, M., Stewart, A.F., Barbalic, M., Gieger, C. et al. (2011) Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat. Genet., 43, 333-338.
53. Bilguvar, K., Yasuno, K., Niemela, M., Ruigrok, Y.M., von Und Zu, F.M., van Duijn, C.M., van den Berg, L.H., Mane, S., Mason, C.E., Choi, M. et al. (2008) Susceptibility loci for intracranial aneurysm in European and Japanese populations. Nat. Genet., 40, 1472-1477.
54. Jarinova, O., Stewart, A.F., Roberts, R., Wells, G., Lau, P., Naing, T., Buerki, C., McLean, B.W., Cook, R.C., Parker, J.S. and McPherson, R. (2009) Functional analysis of the chromosome 9p21.3 coronary artery disease risk locus. Arterioscler. Thromb. Vasc. Biol., 29, 1671-1677.
55. Folkersen, L., Kyriakou, T., Goel, A., Peden, J., Malarstig, A., Paulsson-Berne, G., Hamsten, A., Hugh, W., Franco-Cereceda, A., Gabrielsen, A. and Eriksson, P. (2009) Relationship between CAD risk genotype in the chromosome 9p21 locus and gene expression. Identification of eight new ANRIL splice variants. PLoS One, 4, e7677.
56. Cunnington, M.S., Santibanez, K.M., Mayosi, B.M., Burn, J. and Keavney, B. (2010) Chromosome 9p21 SNPs associated with multiple disease phenotypes correlate with ANRIL expression. PLoS Genet., 6, e1000899.
57. Kotake, Y., Nakagawa, T., Kitagawa, K., Suzuki, S., Liu, N., Kitagawa, M. and Xiong, Y. (2011) Long non-coding RNA ANRIL is required for the PRC2 recruitment to and silencing of p15(INK4B) tumor suppressor gene. Oncogene, 30, 1956-1962.
58. Yu, W., Gius, D., Onyango, P., Muldoon-Jacobs, K., Karp, J., Feinberg, A.P. and Cui, H. (2008) Epigenetic silencing of tumour suppressor gene p15 by its antisense RNA. Nature, 451, 202-206.
59. Mortensen, U.H., Lisby, M. and Rothstein, R. (2009) Rad52. Curr. Biol., 19, R676-R677.
60. Khanna, K.K. and Jackson, S.P. (2001) DNA double-strand breaks: signaling, repair and the cancer connection. Nat. Genet., 27, 247-254.
61. Danoy, P., Michiels, S., Dessen, P., Pignat, C., Boulet, T., Monet, M., Bouchardy, C., Lathrop, M., Sarasin, A. and Benhamou, S. (2008) Variants in DNA double-strand break repair and DNA damage-response genes and susceptibility to lung and head and neck cancers. Int. J. Cancer, 123, 457-463.
62. Liu, J.Z., Tozzi, F., Waterworth, D.M., Pillai, S.G., Muglia, P., Middleton, L., Berrettini, W., Knouff, C.W., Yuan, X., Waeber, G. et al. (2010) Meta-analysis and imputation refines the association of 15q25 with smoking quantity. Nat. Genet., 42, 436-440.
63. Saccone, N.L., Culverhouse, R.C., Schwantes-An, T.H., Cannon, D.S., Chen, X., Cichon, S., Giegling, I., Han, S., Han, Y., Keskitalo-Vuokko, K. et al. (2010) Multiple independent loci at chromosome 15q25.1 affect smoking quantity: a meta-analysis and comparison with lung cancer and COPD. PLoS Genet., 6, e1001053.
64. Saccone, N.L., Schwantes-An, T.H., Wang, J.C., Grucza, R.A., Breslau, N., Hatsukami, D., Johnson, E.O., Rice, J.P., Goate, A.M. and Bierut, L.J. (2010) Multiple cholinergic nicotinic receptor genes affect nicotine dependence risk in African and European Americans. Genes Brain Behav., 9, 741-750.
65. Pesch, B., Kendzia, B., Gustavsson, P., Jockel, K.H., Johnen, G., Pohlabeln, H., Olsson, A., Ahrens, W., Gross, I.M., Bruske, I. et al. (2012) Cigarette smoking and lung cancer-relative risk estimates for the major histological types from a pooled analysis of case-control studies. Int. J. Cancer, 131, 1210-1219.
66. Postel-Vinay, S., Vanhecke, E., Olaussen, K.A., Lord, C.J., Ashworth, A. and Soria, J.C. (2012) The potential of exploiting DNA-repair defects for optimizing lung cancer treatment. Nat. Rev. Clin. Oncol., 9, 144-155.
67. Field, J.K., Smith, D.L., Duffy, S. and Cassidy, A. (2005) The Liverpool Lung Project research protocol. Int. J. Oncol., 27, 1633-1645.
68. Eisen, T., Matakidou, A. and Houlston, R. (2008) Identification of low penetrance alleles for lung cancer: the GEnetic Lung CAncer Predisposition Study (GELCAPS). BMC Cancer, 8, 244.
69. Power, C. and Elliott, J. (2006) Cohort profile: 1958 British birth cohort (National Child Development Study). Int. J. Epidemiol., 35, 34-41.
70. Sauter, W., Rosenberger, A., Beckmann, L., Kropp, S., Mittelstrass, K., Timofeeva, M., Wolke, G., Steinwachs, A., Scheiner, D., Meese, E. et al. (2008) Matrix metalloproteinase 1 (MMP1) is associated with early-onset lung cancer. Cancer Epidemiol. Biomarkers Prev., 17, 1127-1135.
71. Su, L., Zhou, W., Asomaning, K., Lin, X., Wain, J.C., Lynch, T.J., Liu, G. and Christiani, D.C. (2006) Genotypes and haplotypes of matrix metalloproteinase 1, 3 and 12 genes and the risk of lung cancer. Carcinogenesis, 27, 1024-1029.
72. Landi, M.T., Consonni, D., Rotunno, M., Bergen, A.W., Goldstein, A.M., Lubin, J.H., Goldin, L., Alavanja, M., Morgan, G., Subar, A.F. et al. (2008) Environment And Genetics in Lung cancer Etiology (EAGLE) study: an integrative population-based case-control study of lung cancer. BMC Public Health, 8, 203.
73. 1994 The alpha-tocopherol, beta-carotene lung cancer prevention study: design, methods, participant characteristics, and compliance. The ATBC Cancer Prevention Study Group. Ann. Epidemiol., 4, 1-10.
74. Hayes, R.B., Sigurdson, A., Moore, L., Peters, U., Huang, W.Y., Pinsky, P., Reding, D., Gelmann, E.P., Rothman, N., Pfeiffer, R.M. et al. (2005) Methods for etiologic and early marker investigations in the PLCO trial. Mutat. Res., 592, 147-154.
75. Calle, E.E., Rodriguez, C., Jacobs, E.J., Almon, M.L., Chao, A., McCullough, M.L., Feigelson, H.S. and Thun, M.J. (2002) The American Cancer Society Cancer Prevention Study II Nutrition Cohort: rationale, study design, and baseline characteristics. Cancer, 94, 2490-2501.
76. Scelo, G., Constantinescu, V., Csiki, I., Zaridze, D., Szeszenia-Dabrowska, N., Rudnai, P., Lissowska, J., Fabianova, E., Cassidy, A., Slamova, A. et al. (2004) Occupational exposure to vinyl chloride, acrylonitrile and styrene and lung cancer risk (europe). Cancer Causes Control, 15, 445-452.
77. Omenn, G.S., Goodman, G., Thornquist, M., Grizzle, J., Rosenstock, L., Barnhart, S., Balmes, J., Cherniack, M.G., Cullen, M.R. and Glass, A. (1994) The beta-carotene and retinol efficacy trial (CARET) for chemoprevention of lung cancer in high risk populations: smokers and asbestos-exposed workers. Cancer Res., 54, 2038s-2043s.
78. Holmen, J., Midthjell, K., Krüger, O., Langhammer, A., Holmen, T.L., Bratberg, G.H., Vatten, L. and Lund-Larsen, P.G. (2003) The Nord-Trøndelag Health Study 1995-97 (HUNT 2):Objectives, contents, methods and participation. Norsk Epidemiologi, 13, 19-32.
79. Feyler, A., Voho, A., Bouchardy, C., Kuokkanen, K., Dayer, P., Hirvonen, A. and Benhamou, S. (2002) Point: myeloperoxidase -463G -. a polymorphism and lung cancer risk. Cancer Epidemiol. Biomarkers Prev., 11, 1550-1554.
80. Nelis, M., Esko, T., Magi, R., Zimprich, F., Zimprich, A., Toncheva, D., Karachanak, S., Piskackova, T., Balascak, I., Peltonen, L. et al. (2009) Genetic structure of Europeans: a view from the North-East. PLoS One, 4, e5472.
81. Valk, K., Vooder, T., Kolde, R., Reintam, M.A., Petzold, C., Vilo, J. and Metspalu, A. (2010) Gene expression profiles of non-small cell lung cancer: survival prediction and new biomarkers. Oncology, 79, 283-292.
82. Clayton, D.G., Walker, N.M., Smyth, D.J., Pask, R., Cooper, J.D., Maier, L.M., Smink, L.J., Lam, A.C., Ovington, N.R., Stevens, H.E. et al. (2005) Population structure, differential bias and genomic control in a large-scale, case-control association study. Nat. Genet., 37, 1243-1246.
83. Howie, B.N., Donnelly, P. and Marchini, J. (2009) A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet., 5, e1000529.
84. Li, Y., Willer, C.J., Ding, J., Scheet, P. and Abecasis, G.R. (2010) MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes. Genet. Epidemiol., 34, 816-834.
85. Li, Y., Willer, C., Sanna, S. and Abecasis, G. (2009) Genotype imputation. Annu. Rev. Genomics Hum. Genet., 10, 387-406, 387-406.
86. Howie, B., Fuchsberger, C., Stephens, M., Marchini, J. and Abecasis, G. (2012) Fast and accurate genotype imputation in genome-wide association studies through pre-phasing. Nat. Genet., 44, 955-959.
87. Aulchenko, Y.S., Ripke, S., Isaacs, A. and van Duijn, C.M. (2007) GenABEL: an R library for genome-wide association analysis. Bioinformatics, 23, 1294-1296.
88. Higgins, J.P., Thompson, S.G., Deeks, J.J. and Altman, D.G. (2003) Measuring inconsistency in meta-analyses. Br Med J, 327, 557-560.
89. Altshuler, D., Daly, M.J. and Lander, E.S. (2008) Genetic mapping in human disease. Science, 322, 881-888.
90. Purcell, S. (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet., 81, 559-575.
91. Pruim, R.J., Welch, R.P., Sanna, S., Teslovich, T.M., Chines, P.S., Gliedt, T.P., Boehnke, M., Abecasis, G.R. and Willer, C.J. (2010) LocusZoom: regional visualization of genome-wide association scan results. Bioinformatics, 26, 2336-2337.
92. Gauderman, W.J. (2002) Sample size requirements for matched case-control studies of gene-environment interaction. Stat. Med., 21, 35-50.